Cited by 437Inflammatory Bowel DiseaseAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access

The Manitoba IBD Cohort Study: A Population-Based Study of the Prevalence of Lifetime and 12-Month Anxiety and Mood Disorders

Walker, John R., Ediger, Jason P., Graff, Lesley A., Greenfeld, Jay M., Clara, Ian, Lix, Lisa, Rawsthorne, Patricia, Miller, Norine +3 more·2008·The American Journal of Gastroenterology

Abstract

BACKGROUND AND AIMS: Given the impact of anxiety and mood disorders on health, it is important to consider these disorders in persons with inflammatory bowel disease (IBD). We assessed the prevalence of anxiety and mood disorders in a population-based IBD cohort. METHODS: A structured diagnostic interview was administered to participants in the cohort (N = 351), and rates were compared to age-, gender-, and region-matched controls drawn from a national survey (N = 779). RESULTS: A comparison of lifetime prevalence suggests higher rates of panic, generalized anxiety, and obsessive-compulsive disorders and major depression and lower rates of social anxiety and bipolar disorders in the IBD sample than in national samples in the United States and New Zealand. Direct comparisons with matched controls (with data available for three anxiety disorders) found lifetime prevalence (IBD vs controls) as follows: social anxiety disorder lower in IBD (6%vs 11%, OR 0.52, 95% CI 0.32-0.85), panic disorder not significantly different (8.0%vs 4.7%, OR 1.59, 95% CI 0.96-2.63), agoraphobia without panic not significantly different (1.1%vs 0.6%, OR 1.44, 95% CI 0.37-5.55), and major depression higher (27.2%vs 12.3%, OR 2.20, 95% CI 1.64-2.95). Comparing IBD respondents with and without lifetime anxiety or mood disorder, those with a disorder reported lower quality of life and earlier onset of IBD symptoms and there was a trend toward earlier IBD diagnosis. CONCLUSIONS: Clinicians should be aware of the increased prevalence of depression and possibly other anxiety disorders in persons with IBD as these disorders may influence response to treatment and quality of life.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1572-0241.2008.01980.x

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Comorbid psychological difficulties in IBD are associated with disease activity, flares, treatment response, and the necessity of surgical intervention.

    “Indeed, comorbid psychological difficulties are associated with disease activity, flares, treatment response, and the necessity of surgical intervention [2,6,8,9,10,11,12,13,14,15].”

    From Brief and Telehealth Acceptance and Commitment Therapy (ACT) Interventions for Stress in Inflammatory Bowel Disease (IBD): A Series of Single Case Experimental Design (SCED) Studies (2022) · cites this paper as [6]

    The Discussion (p. 14) reports associations between depressive symptoms and earlier, more frequent relapses, later disease activity, and failure to achieve remission with infliximab. It does not link psychological difficulties to a need for surgical intervention; its reference to an earlier need for reinitiation of treatment is not surgery. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Approximately two-thirds of patients who had both anxiety disorder and IBD developed psychiatric symptoms predating the IBD diagnosis by over 2 years.

    “The report showed that approximately two-thirds of patients who had both anxiety disorder and IBD actually developed psychiatric symptoms predating the IBD diagnosis by over 2 years.”
  • IBD patients with lifelong anxiety or mood disorders displayed an earlier onset of IBD symptoms than those without such disorders, with a tendency for early diagnosis of IBD.

    “Moreover, IBD patients with lifelong anxiety or mood disorders displayed an earlier onset of IBD symptoms than those without the above disorders, and there was a tendency for an early diagnosis of IBD (75).”
  • More than half of IBD patients with mood disorders had a more than 2-year time interval for diagnosis.

    “This more than 2-year time interval for diagnosis was also present in more than half of IBD patients with mood disorders.”
  • Eleven of 13 studies measuring anxiety in controversy 1 found significantly higher rates or levels of anxiety in IBD than in healthy controls.

    “Eleven of the 13 studies measured anxiety, with seven of these reporting either significantly higher rates (% or levels (mean scores) of anxiety in those with IBD than in healthy control participants (n=3,262 IBD; n=12,024 controls) (9, 15, 20-22, 24, 26).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [18]18. Gravel R, Béland Y. The Canadian Community Health Survey: mental health and wellbeing. Can J Psychiatry 2005;50(10):573-9.
  2. [26]26. Masse R, Poulin C, Dassa C, et al. Elaboration and validation of a tool to measure psychological well-being: WBMMS. Can J Public Health 1998;89:352-357.

Cited by

Sorted by citations

Authors
Walker, J. R., Ediger, J. P., Graff, L. A., Greenfeld, J. M., Clara, I., Lix, L., Rawsthorne, P., Miller, N., Rogala, L., McPhail, C. M., & Bernstein, C. N.
Affiliations
University of Manitoba (CA)
Corresponding author
Bernstein, Charles N.
Venue
The American Journal of Gastroenterology
Published
2008-08
Volume
103
Issue
8
Pages
1989-1997
ISSN
  • 0002-9270 (ISSN-L)
  • 1572-0241
OpenAlex
W2093986077
Cited by
437
References
47
Citations by year
2026: 11 · 2025: 16 · 2024: 24 · 2023: 25 · 2022: 42 · 2021: 43 · 2020: 32 · 2019: 30 · 2018: 29 · 2017: 27 · 2016: 36 · 2015: 28 · 2014: 18 · 2013: 21 · 2012: 17
FWCI
7.24
Type
journal article
Language
en
Open access
closed
Locations
  • The American Journal of Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
  • Mspace (University of Manitoba) (submittedVersion)
Funders
  • University of Manitoba
  • Crohn's and Colitis Foundation
  • Crohn's and Colitis Foundation of Canada
  • Canadian Institutes of Health Research
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
Keywords
inflammatory bowel disease, anxiety disorders, mood disorders, depression, panic disorder, generalized anxiety disorder, obsessive-compulsive disorder, social anxiety disorder, agoraphobia, lifetime prevalence, 12-month prevalence, quality of life
MeSH terms
Adult, Aged, Aged, 80 and over, Anxiety Disorders, Chronic Disease, Female, Health Surveys, Humans, Male, Manitoba, Middle Aged, Inflammatory Bowel Diseases, Cohort Studies, Prevalence, Case-Control Studies, Mood Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review